Introduction {#dew214s10}
============

As the number of children born from assisted reproductive technologies has been increasing over the years, the question of safety of ART procedures, including *in vitro* culture, has become a prevalent issue for public health. Indeed, the recommendations to reduce multiple pregnancies after IVF and ICSI suggest an increase in the duration of *in vitro* culture before selecting the embryo to be transferred.

Two main *in vitro* culture strategies are currently used. 'Sequential' media are designed to mimic the environmental changes that occur *in vivo* when the embryo progresses in the oviduct to the uterus. 'One-step' media, on the other hand, are designed to contain all that the embryo needs for all stages of preimplantation development, arguing that brutal environmental changes are detrimental to the embryo, which needs to adapt ([@dew214C57]). An additional advantage is that they are compatible with uninterrupted culture associated with the use of time-lapse technology. However, it remains impossible to this day to say which approach is superior ([@dew214C33]; [@dew214C50]), especially since studies in the human are made difficult by numerous confounding effects. Studies on animal models have shown that the environment surrounding oogenesis and the first steps of embryonic development influences the phenotype and can have effects during the animal\'s whole life ([@dew214C12]), thus extending the concept of Developmental Origin of Health and Diseases (DOHaD) to the periconceptional period. These long term effects likely result from environment-induced epigenetic modifications in a sensitive period of intense epigenetic remodeling ([@dew214C57], [@dew214C58]; [@dew214C16]), leading to subsequent changes in gene expression ([@dew214C4]).

DNA methylation on cytosines (5-methylcytosine: 5meC) is an essential epigenetic modification that seems to be particularly affected by *in vitro* culture ([@dew214C60]) and to have an impact on the health of children born after ART, in particular through misregulation of imprinted genes ([@dew214C10]; [@dew214C7]), leading to rare syndromes such as Beckwith--Wiedemann and Angelman ([@dew214C32]; [@dew214C39]; [@dew214C26]). In addition to its importance in imprinting, DNA methylation is involved in the regulation of many developmental processes such as parental imprinting, X-inactivation and control of endogenous retrotransposons ([@dew214C58]; [@dew214C8]). Methylation at gene promoters is generally associated with transcriptional repression ([@dew214C23]). This mark is submitted to intense remodeling events during embryonic development. In mice, a major demethylation phase occurs during the 1-cell stage and further demethylation is ongoing until the blastocyst stage ([@dew214C34]; [@dew214C29]; [@dew214C48]; [@dew214C49]; [@dew214C56]; [@dew214C14]). In rabbits, although DNA methylation is submitted to many changes during the 1-cell stage in both parental genomes ([@dew214C45]), the real demethylation phase starts later, after the 4-cell stage ([@dew214C46]). Demethylation of the human genome appears less clear; while an initial report had described a similar kinetics to that of rabbit embryo ([@dew214C13]), a more recent report has shown that demethylation of human embryos is complete by the end of the 2-cell stage ([@dew214C15]). Differences in the timing of DNA demethylation between various species could be related to the timing of embryonic genome activation (EGA), which occurs at the 2-cell stage in mouse embryos but at the 4/8-cell stage in human embryos and around the 8-cell stage in rabbit embryos (([@dew214C54]) and our own unpublished data).

Active DNA demethylation can be ensured by several indirect processes (review ([@dew214C18])) but it is now clearly established that oxidation of 5meC to 5-hydroxymethylcytosine (5hmeC) by enzymes of the ten eleven translocation (TET) family is the first step in the main active demethylation process ([@dew214C52]; [@dew214C21]), particularly in early embryos ([@dew214C20]; [@dew214C59]). However, the dynamics of DNA hydroxymethylation during early development ([@dew214C29]; [@dew214C48]) suggests that 5hmeC has functions of its own. In particular, it seems important for pluripotence of mouse embryonic stem cells ([@dew214C52]; [@dew214C21]; [@dew214C24]; [@dew214C9]) and is preferentially associated with transcriptionally active genes ([@dew214C11]; [@dew214C41]; [@dew214C61]; [@dew214C62]; [@dew214C25]; [@dew214C35]). Studies reporting a link between 5hmeC and many diseases, in particular cancers (review ([@dew214C55])) and neurologic disorders such as autism ([@dew214C40]), have also greatly increased over the last few years. Due to its link to DNA demethylation and to these functions, 5hmeC appears as a potential crucial mark during early development.

In the present study, we chose to use both DNA hydroxymethylation and DNA methylation to assess the two types of culture conditions ('sequential' versus 'one-step'), using respectively the G-1™ PLUS/G-2™ PLUS (G1+/G2+) media (Vitrolife) and the global^®^(Global) medium (LifeGlobal^®^), which are most commonly used in ART in France, by comparing embryos cultured in these media to *in vivo* developed embryos. Due to ethical as well as technical considerations, this type of study cannot be conducted using human embryos. We chose to use rabbit embryos as a model as its characteristics are much closer to human embryo than the more traditional mouse model. As already mentioned above, the timing of EGA in rabbit embryos is closer to that of human embryos than mouse, which is apart from most mammalian species. This can lead to very different epigenetic reprogramming timing and mechanisms between mouse and other mammalian species, as we have shown in the case of X-chromosome inactivation ([@dew214C38]). In addition, the metabolism of rabbit embryos is very close to human embryos ([@dew214C31]; [@dew214C22]; [@dew214C6]; [@dew214C5]; [@dew214C1]), which is essential for two reasons: first, to ensure that consumption of the medium nutrients are comparable in both species; and second, because there is a direct link between metabolism and DNA methylation, through the production of the methyl donor S-adenosyl methionine (SAM) ([@dew214C37]).

We analyzed the evolution of DNA hydroxymethylation and methylation using quantitative immunofluorescence in embryos produced *in vivo* or cultured in either G1+/G2+ or Global media. We then assessed whether the observed differences could be related to changes in the expression of DNA methylation related enzymes (DNA methyltransferases (DNMT) and TET dioxigenases). Finally, because the expression of endogenous retroviral sequences is known to be repressed by DNA methylation ([@dew214C47]), we examined the impact of *in* *vitro* culture on the expression of two endogenous retroviral sequences.

Material and methods {#dew214s11}
====================

Ethics {#dew214s11a}
------

Animal care and handling were carried out according to European regulations on animal welfare. ND, VD, NB and JS have the authorization to work with laboratory animals from the departmental veterinary regulatory services (No 78--73, 78--101, 78--95 and 78--137, respectively). This work has been approved by the local ethics committee (Comethea Jouy-en-Josas/AgroParisTech: agreements 12/107 and 14/35 for *in vitro* analyses and embryo transfer experiments respectively).

Animals {#dew214s11b}
-------

New Zealand White female rabbits were superovulated as follows: five subcutaneous administrations of pFSH (Stimufol^®^, Merial, France) were performed during the 3 days prior to mating (two 5 µg doses on the first day with a 12-h interval, two 10 μg doses on the second day with a 12-h interval, and one 5 μg dose on the third day), followed 12 hours later by an intravenous administration of 30 IU HCG (Chorulon, MSD Animal Health, USA) at the time of mating (natural mating with New Zealand White male rabbits).

Recovery of rabbit embryos {#dew214s11c}
--------------------------

*In vivo* developed embryos were collected from oviducts perfused with Dulbecco\'s Phosphate Buffer Saline (PBS) at the following stages: 1-cell (19 h post-coitum (hpc)), 2-cell (24 hpc), 4-cell (32 hpc), 8-cell (49 hpc), 16-cell (55 hpc), morula (67 hpc) and blastocyst (80, 88 and 96 hpc). Embryos were always collected from a minimum of two female rabbits.

Embryos for the *in vitro* culture experiments were all collected at the 1-cell stage (19 hpc). They were rinsed and put in culture in 40 µl drops of either preheated and pre-equilibrated G-1™ PLUS (G1+) medium (Vitrolife, Sweden) or global^®^ (Global) medium supplemented with 10% Human Serum Albumin (HSA, LifeGlobal^®^, Canada) under mineral oil (Sigma-Aldrich, USA) in an incubator at 38°C under 5% CO~2~ in air. For each experiment, we took care of the following parameters: ensuring that embryos cultured in both media were treated in the same way and minimizing the time the embryos spent out of the incubator. With this aim, we prepared one dish containing three drops of each medium for each stage of fixation. In addition, embryos were always collected from a minimum of three female rabbits and sorted into 6--10 pools depending on the number collected so that each pool contained an equivalent amount of embryos from each rabbit. Embryos cultured *in vitro* to the 2-, 4- and 8-cell stages were processed at, respectively, 27, 33 and 49 hpc; at 49 hpc, embryos that were to be kept in culture until later stages were transferred to new drops of media, G-2™ PLUS (G2+) for those that were in G1+, and Global+10% HSA, for those that were already in Global medium. Then 16/32-cell stage embryos, morulae and blastocysts were processed respectively at 57, 72 and 98 hpc. All media were prepared the evening before use and put in the incubator for gas equilibration. Embryos used for molecular biology were snap-frozen in dry ice.

Embryo transfer {#dew214s11d}
---------------

Pseudopregnancy was induced by intramuscular injection of 0.8 µg of buserelin (0.2 ml of Receptal, Intervet, Angers France) with a 24--28 h delay (asynchronisation) in comparison to the protocol used for embryos donor rabbits. The embryos were transferred surgically into the oviducts of the pseudopregnant rabbits by laparotomy under general gas (isoflurane) anesthesia as performed routinely in the laboratory. A few minutes before surgery, recipients received one intramuscular injection of ketamine (Imalgen 1000), one intravenous injection of meloxicam (Metacam, Boehringer Ingelheim, Alcyon) and one subcutaneous injection of enrofloxacine (Alcyon). At 24.5 days after transfer (D28 embryonic age), females were euthanized, and implantations and fetuses were counted.

Immunostaining {#dew214s11e}
--------------

*In vivo* collected embryos were incubated in 5 mg/ml Pronase (Sigma-Aldrich, USA) at room temperature (RT) to remove the zona pellucida and mucin coat. All embryos were fixed and treated as previously described ([@dew214C46]). For technical reasons, we could not process *in vivo* developed embryos in the same experiments as *in vitro* cultured ones. However, in all experiments we processed, at the same time, a minimum of three different stages of either *in vivo* developed or embryos cultured in both media. The 4-cell stage was always included as an internal reference. Briefly, embryos were fixed in 4% paraformaldehyde (PAF, Sigma-Aldrich, USA) in PBS overnight at 4°C and permeabilized with 0.5% Triton X-100 (Sigma-Aldrich, USA) in PBS for 1 h on a heating plate at 25°C. DNA denaturation was performed using 2 M HCl for 1 h on a heating plate at 25°C. After a 1 h incubation in PBS containing 2% BSA at room temperature, incubation in the primary antibody, either anti-5methylcytosine (5meC 1:500; BI-MECY, Eurogentec, Belgium) or anti-5hydroxymethylcytosine, (5hmeC 1:500; \#39769 Active Motif, Belgium) was performed overnight at 4°C. Embryos were incubated the next day in the secondary antibody, either FITC-conjugated anti-mouse (for 5meC) or AlexaFluor488-conjugated anti-rabbit (for 5hmeC) (1:200 dilution; respectively \#715-095-151 and \#715-545-152, Jackson ImmunoResearch, USA), for 1 h at room temperature. DNA was counterstained using 2 µM Ethidium Homodimer-2 (EthD2, Invitrogen, USA) for 30 min at 37°C. The embryos were mounted in Citifluor (AF1, BioValley, France).

Signal quantifications {#dew214s11f}
----------------------

The embryos were observed using a Carl Zeiss (Germany) AxioObserver Zl fluorescence microscope equipped with the ApoTome slider (MIMA2 Platform, INRA). The samples were observed for the area containing the nuclei with a 63x Plan-Neofluar oil objective (NA 1.3) and digital optical sections were collected using a Z-series acquisition feature every 0.5 µm. Quantitative analyses of DNA methylation levels and total DNA contents were estimated by quantifying fluorescence signals using Image-J software (National Institute of Health, Bethesda, Maryland, USA) as follows: (i) the z-range was determined for each nucleus and a summing z-projection was realized; (ii) the area of each nucleus was outlined manually and the mean fluorescence intensity was measured for both 5hmeC/5meC and EthD-2 images; (iii) the mean background was determined for each nucleus in its immediate vicinity and subtracted from the measured signal; (iv) the mean fluorescence signal obtained was multiplied by the corresponding nucleus area to obtain the total fluorescence signal; (v) the total fluorescence intensities were normalized by the acquisition time of the corresponding signal; and (vi) the total fluorescence measured for 5hmeC/5meC in each nucleus was corrected by the corresponding measure of EthD-2. Each stage was present in at least two (*in vivo* developed embryos) or three (*in vitro* produced embryos) independent experiments, except for the 4-cell stage which was always included. Data from each replicate were normalized by the median of the 4-cell early stage of the same replicate. For embryos at the 4- and 8-cell stages, we calculated the median of all DNA content measures on embryos from one experimental set (all stages pooled together): those with a DNA content inferior to the median were considered to be in the early phases of the cell cycle (G1 and early S phase) while those with a higher DNA content were considered to be in the later phases of the cell cycle (late S and G2).

RNA isolation, reverse transcription and qPCR {#dew214s11g}
---------------------------------------------

Total RNA was isolated from batches of embryos (*n* = 20 for all stages except blastocyst stage *n* = 10) using PicoPur Arcturus (Excilone, France) with a DNase I (Qiagen, Germany) treatment as recommended by the supplier. To control the quality of 'Isolation-RT' procedure *a posteriori*, we proceeded as described in [@dew214C43]. The reverse transcription reaction was performed on the same number of 'equivalent embryos' at each stage by the Superscript III enzyme and primed by random hexamers (300 ng) (Lifetechnologies, France) following the supplier\'s protocol (25°C for 5 min, 50°C for 60 min and 70°C for 15 min).

qPCR conditions {#dew214s11h}
---------------

A pilot experiment was conducted to determine the optimal conditions of use of the primers and to define the number of 'equivalent embryos' required for PCR for each embryonic stage and gene (Table [I](#dew214TB1){ref-type="table"}). The primers used for the endogenous reference gene*s (Hprt1 and Ywhaz)* have been published by [@dew214C30] and the Luciferase primers have been previously published [@dew214C3]. Primers for the genes of interest were designed using Primers Express software (Applied Biosystems, USA). The *ERVA* and *ERVB* primers were defined from expressed sequence tags (ESTs) identified from a cDNA library corresponding to genes expressed at the morula stage. Details for primers are reported in Table [II](#dew214TB2){ref-type="table"}. qPCR reactions were performed on a Step One Plus machine (Applied Biosystems, USA) in 25 µl volume containing 12.5 µl of Sybr Green PCR Master Mix (Applied Biosystems, USA), primers and cDNAs. The thermal cycle profile was: 10 min at 95°C then 40 cycles with 15 s at 95°C and 60 s at 60°C except for *Ywhaz* and *Hprt1* (68°C). Dissociation curves were obtained after each PCR run to ensure that a single PCR product had been amplified. The specificity of amplicons was verified by sequence alignment on the rabbit genome. Table INumber of 'equivalent embryos' used for each qPCR reaction.GeneEmbryonic stages2PN to morulaBlastocyst*Dnmt1*0.20.2*Dnmt3A*0.20.05*Dnmt3B*0.50.05*Tet1*0.50.05*Tet2*0.50.05*Tet3*0.50.5*ERVA*0.20.2*ERVB*0.20.2*Luc, Hprt1 and Ywhaz*0.20.2 Table IIPrimers and PCR features.GeneAccession numberPrimer sequence (nM)Size (bp)Annealing temperature (°C)*Hprt1* ([@dew214C30])ENSOCUG00000003186F: ACGTCGAGGACTTGGAAAGGGTGTT (200 nM)9668R: GGCCTCCCATCTCCTTCATCACATC (200 nM)*Ywhaz* ([@dew214C30])ENSOCUG00000000734F: GGTCTGGCCCTTAACTTCTCTGTGTTCTA (200 nM)14268R: GCGTGCTGTCTTTGTATGATTCTTCACTT (200 nM)*Luciferase* ([@dew214C3])M15077F: AGAGATACGCCCTGGTTCCT (100 nM)25960R: ATAAATAACGCGCCCAACAC (100 nM)*H2afz*ENSOCUG00000001888F: AGAGCCGGCTGCCAGTTCC (200 nM)8560R: CAGTCGCGCCCACACGTCC (200 nM)*TET1*ENSOCUT00000007207F: AGAAGCCATCCGTCCTTGTG (300 nM)10160R: TTTGTTGCCAATATCTGCCTTTAA (300 nM)*TET2*ENSOCUT00000007098F: GTGCTCACGCCCACAGAGA (300 nM)12460R: GGCAGAACGTGGAGCTGCT (300 nM)*TET3*ENSOCUT00000030004F: AACCAGGTGACCAATGAAGAAATAG (300 nM)17560R: AGCGATTGTCTTCCTTGGTCAG (300 nM)*Dnmt1*ENSOCUT00000008429F: CATCGACACCGGCCTCA (200 nM)10260R: CCATTGACACCGCCTTCCT (200 nM)*Dnmt3A*ENSOCUT00000030812F: CTGTCCCAGCTGAAAAGAGGAA (200 nM)10060R: TCCACCTGGATGCCCAAGT (200 nM)*Dnmt3B*ENSOCUT00000017835F: GTAGGCGGCCCATTCGA (200 nM)10060R: GAAGCGACGTACTTTTCCACCTT (200 nM)*ERVA*CU 465723F: GGGTGTCCAATGACGGGTAAG (200 nM)15160R: GCCGGGAAGTCTCCATTCA (200 nM)*ERVB*CU 465570F: TCCTTCGCATCTGGATTGTCA (200 nM)11960R: ACAAACACCACAGGCAAAATAACAC (200 nM)[^1]

For each qPCR, the efficiency was determined by serial dilutions of iPS cells cDNA ([@dew214C64], iPS cells kindly provided by Pierre Savatier). For each sample, PCR was performed in triplicate.

The results presented in this study were initially obtained from three biological repeats, when a difference between two conditions was found significant or close to significance, three additional repeats were performed to verify the differences.

For each PCR, starting from experimentally obtained Ct values, we inferred the Ct corresponding to one embryo for each gene and each stage, using the standard curve. Then data analysis was performed using the qBase Plus software (Biogazelle, Belgium) ([@dew214C17]). *Ywhaz* and *Hprt1* were used to normalize the results according to the GeNorm procedure. A ΔΔCt method taking into account the efficiency of each qPCR was used to determine the relative normalized expression level of each gene of interest.

Statistical analysis {#dew214s11i}
--------------------

For 5meC and 5hmeC quantification, statistical analyses were performed using the pairwise.perm.t.test (with 10 000 permutations) from the RVAideMemoire package in the R software ([@dew214C44]). Statistical analysis of RT-qPCR data was performed using non-parametric tests in the R software: K-Sample-Fisher Pitman Permutation test from the 'coin' package and non-parametric relative contrast effect (nparcomp) from the 'nparcomp' package.

Results {#dew214s12}
=======

Development of rabbit embryos in human culture media {#dew214s12a}
----------------------------------------------------

In order to confirm that rabbit embryos could provide a valuable model to study the effect of media commonly used in ART procedures, we first followed their development in those media. For each experiment, about 60 embryos were collected at the 1-cell stage from two female rabbits and placed in either G1+ or Global medium. In order to mimic the procedures used in ART, we transferred the embryos to a new dish at the 8-cell stage either to change the medium (G2+ instead of G1+) or to refresh the medium (Global). Based on our expertize of the timeline of rabbit embryos development in other commonly used media, we chose to assess development at given time points corresponding to key preimplantation stages ([@dew214C46] and our unpublished data).

As can be seen in Fig. [1](#dew214F1){ref-type="fig"}A, at all chosen time points, we observed that over 80% of embryos were at the expected developmental stage, showing that rabbit embryo development in media designed for human embryos follows the same kinetics with the same development rates as that previously observed in other commonly used media. Those time points were used for the rest of the experiments. Figure 1Development of rabbit embryos after culture in G1+/G2+ and Global media. Panel **A:** preimplantation development. Percentage of embryos collected at the 1-cell stage that had reached a given stage (2c: 2-cell; 4c: 4-cell; 8c: 8-cell; 16c: 16-cell; mor: morula; bl: blastocyst) at a given time point (expressed in hours post-coïtum). Time points were chosen accordingly to our expertize of New Zealand White rabbit *in vitro* development. Embryos from four different rabbits (obtained in two independent experiments) were separated in dishes (one dish per time point) so as to minimize the time spent out of the incubator. At the 8-cell stage, i.e. the time of medium change, and at the blastocyst stage, end point of the experiments, the development of embryos from all dishes was assessed. A total of 60 embryos (30 for each medium) were followed. Panel **B:** development after embryonic transfer. Recipient female rabbits were sacrificed at Day 28 and the percentages of embryos that had properly implanted (implantation) and developed to the proper stage (fetuses at day 28) are shown on the graphic. totals of 60 embryos (G1+/G2+) and 39 embryos (Global) were transferred respectively into three and two recipient females and analyzed at Day 28.

Rabbit development to term after embryo culture in human culture media {#dew214s12b}
----------------------------------------------------------------------

To determine whether *in vitro* culture of rabbit embryos was compatible with their further development, 60 and 39 embryos cultured in G1+/G2+ and Global respectively were transferred into three and two recipient females after 73 h of culture (blastocyst stage Day 4). At day 28 (embryonic age), 15 and 10 implantations were observed and 12 (20%) and 9 (23%) morphologically normal fetuses were obtained for G1+/G2+ and Global respectively (Fig. [1](#dew214F1){ref-type="fig"}B). These developmental rates were well above those commonly obtained after transfer of blastocysts in this species ([@dew214C63], and our unpublished data).

Effect of ART culture media on DNA hydroxymethylation in rabbit embryos {#dew214s12c}
-----------------------------------------------------------------------

In order to assess the effect of *in vitro* culture in G1+/G2+ and Global media on DNA hydroxymethylation, we used immunofluorescence staining with an antibody specific for 5hmeC and quantified the signal obtained.

Figure [2](#dew214F2){ref-type="fig"} shows the quantification of DNA hydroxymethylation in embryos collected *in vivo* and cultured in the two *in vitro* conditions. As DNA content doubles during the cell cycle, we separated nuclei of 4- and 8-cell embryos into 'early' and 'late' categories based on their DNA content. This separation allowed us to assess the evolution of DNA hydroxymethylation during the cell cycle. We did not separate the 2-cell embryos because we had very few embryos in the 'late' pool for *in vivo* developed embryos. Moreover, as we did not observe differences in DNA hydroxymethylation levels between the 16- and 32-cell stage embryos, we decided to pool them. Finally, all results were normalized by the median of the 4-cell early stage. Figure 2Quantification of DNA hydroxymethylation during rabbit preimplantation development in different conditions. Boxplots showing the 5hmeC/DNA (EthD2) ratios obtained after quantification of immunofluorescence images in embryos developed *in vivo* (Vivo) or cultured in G1+/G2+ (G1+/G2+) or in Global (Global) medium and normalization by the median of the 4-cell early stage for each condition. The number of nuclei analyzed for each developmental stage is indicated below the corresponding stage. Significant differences between two consecutive stages are indicated on the graphic (\**P* \< 0.01; \*\**P* \< 0.005; \*\*\**P* \< 0.001).

In *in vivo* developed embryos, the DNA hydroxymethylation levels significantly increased between the 2- and 4-cell stages. It started decreasing during the 4- and 8-cell stage; no difference was observed between the 4-cell late and 8-cell early stages. At the 16/32-cell stage, DNA hydroxymethylation increased again to reach about the level it had been in 2-cell embryos; it then remained stable at the morula stage. Interestingly, DNA hydroxymethylation behaved differently in the two *in vitro* conditions we compared, and appeared to be much more variable, especially at the later stages. In embryos cultured in Global medium, it followed a similar pattern to that in *in vivo* collected embryos until the 16/32-cell stage, even if the decrease observed at the 4-cell stage was slightly lower ([Supplementary data, Fig. S1](http://HUMREP.oxfordjournals.org/lookup/suppl/doi:10.1093/humrep/dew214/-/DC1/dew214supp_figure1.pdf)). The main difference was observed at the morula stage, where the level of DNA hydroxymethylation significantly increased and became higher than it was at the 2-cell stage. By contrast, in embryos cultured in G1+/G2+ media, differences appeared much earlier. The DNA hydroxymethylation level decreased during the 4- and the 8-cell stages to a roughly similar extent to that observed *in vivo*, but surprisingly there was a significant increase between the 4-cell late and the 8-cell early stages, leading to higher hydroxymethylation levels in 8-cell early but also 8-cell late embryos ([Supplementary data, Fig. S1](http://HUMREP.oxfordjournals.org/lookup/suppl/doi:10.1093/humrep/dew214/-/DC1/dew214supp_figure1.pdf)). Finally, DNA hydroxymethylation decreased again between the 8-cell late and 16/32-cell stages, where it was lower than in the other two conditions, but increased between the 16/32-cell and morula stages. However, like in *in vivo* developed embryos, the final level of DNA hydroxymethylation was close to the level observed in 2-cell embryos. In conclusion, the kinetics of DNA hydroxymethylation in embryos cultured in the Global medium appeared equivalent to that observed in *in vivo* collected embryos until the 16/32-cell stage, but its final level at the morula stage was much higher. In contrast, embryos cultured in G1+/G2+ media showed different kinetics, especially at the time of EGA (8/16-cell stages), but the final level at the morula stage was similar to that observed in *in vivo* collected embryos.

Effect of ART culture media on DNA methylation in rabbit embryos {#dew214s12d}
----------------------------------------------------------------

We had previously shown, using a rabbit specific medium, that *in vitro* culture has an impact on DNA methylation of rabbit embryos. We thus decided to analyze DNA methylation in G1+/G2+ and Global media focusing on the stages where the main differences were observed in our previous study, i.e. between the 2- and the 16/32-cell stages. For comparison, we reused the data previously obtained on*in vivo* collected embryos, ([@dew214C46]), although we separated the 4- and 8-cell stages embryos into 'early' and 'late' categories, as described in the methods.

As shown in Fig. [3](#dew214F3){ref-type="fig"}, we observed that DNA methylation followed a kinetic that is similar to that of DNA hydroxymethylation in *in vivo* collected embryos: increase between the 2- and 4-cell early stages, decrease during the 4-cell stage and the 8-cell stage. There are however two main differences: unlike DNA hydroxymethylation, DNA methylation significantly decreased between the 4-cell late and 8-cell early stages, and there was no increase between the 8- and 16/32-cell stages. Embryos cultured *in vitro* in G1+/G2+ and Global media both showed very different kinetics (Fig. [3](#dew214F3){ref-type="fig"}). No DNA demethylation was observed for embryos cultured in Global medium until the 8-cell stage. In fact, the only demethylation phase seemed to occur during the 8-cell stage. Compared to *in vivo* developed embryos, DNA methylation relative to early 4-cell stage was thus higher in Global whatever the stage ([Supplementary data, Fig. S2](http://HUMREP.oxfordjournals.org/lookup/suppl/doi:10.1093/humrep/dew214/-/DC1/dew214supp_figure2.pdf)). In contrast, in embryos cultured in G1+/G2+ media, demethylation occured both during the 4- and 8-cell stages, and between the 8-cell late and 16/32-cell stages but a sharp increase in DNA methylation was observed between the 4-cell late and 8-cell early stages. It is important to note that at the 8-cell stage DNA methylation levels appeared much more variable after *in vitro* culture than in *in vivo* developed embryos (Fig. [3](#dew214F3){ref-type="fig"}). Figure 3Quantification of DNA methylation during rabbit preimplantation development in different conditions. Boxplots showing the 5meC/DNA (EthD2) ratios obtained after quantification of immunofluorescence images in embryos developed *in vivo*(Vivo) or cultured in G1+/G2+ (G1+/G2+) or in Global (Global) medium and normalization by the median of the 4-cell early stage for each condition. The number of nuclei analyzed for each developmental stage is indicated below the corresponding stage. Significant differences between two consecutive stages are indicated (\**P* \< 0.01; \*\**P* \< 0.005; \*\*\**P* \< 0.001).

Expression of DNA methylation related enzymes after *in vitro* culture {#dew214s12e}
----------------------------------------------------------------------

As we observed differences in both DNA methylation and hydroxymethylation dynamics between *in vivo* developed embryos and *in vitro* cultured ones, we wondered whether these changes could be associated with changes in the expression of genes encoding the related enzymes: *DNMTs* and/or *TET* genes.

We assessed the expression of *DNMT1*, *DNMT3A*, *DNMT3B, TET1, TET2* and *TET3* by RT-qPCR in preimplantation embryos after *in vitro* culture in either G1+/G2+ or Global medium and compared the results to those obtained for*in vivo* developed embryos. We first performed three independent repeats for all stages (Fig. [4](#dew214F4){ref-type="fig"}A). Our results did not show any modifications of *DNMT3A* at any of the analyzed stages. On the other hand, we were able to detect differences in the expression of the five other enzymes at some stages that were either statistically significant or nearly significant. In order to verify those differences, we performed three more repeats for the stages at which we had observed differences (Fig. [4](#dew214F4){ref-type="fig"}B). We could confirm that the expression of *TET1* is significantly decreased after *in vitro* culture in both G1+/G2+ and Global media at the 16-cell (*P* = 0.01) and morula (*P* = 0.003) stages. Similarly, the expression of *TET2* was significantly decreased at the 16-cell stage (*P*= 0.006) after culture in both media. Figure 4Expression of DNA methylation related genes during rabbit preimplantation development in different conditions. Panel **A:** expression of *DNMT1, DNMT3A, DNMT3B, TET1, TET2* and *TET3* in oocytes (Oo) and at the 1-cell (1c), 2-cell (2c), 4-cell (4c), 8-cell (8c), 16-cell (16c), morula (Mo) and blastocyst (Bl) stages. White bars: *in vivo* developed embryos: oocytes and 1-cell embryos are common to all conditions as *in vitro* cultured embryos were collected at the 1-cell stage; grey bars: embryos cultured in Global medium; black bars: embryos cultured in G1+/G2+ media. Each bar represents the mean of three independent experiments with standard deviations and expression levels normalized by the expression level at the 1-cell stage. Panel **B:** Focus on the expression of *DNMT1*, *DNMT3B, TET1, TET2* and *TET3* at certain developmental stages: when a difference detected in the first set of experiments presented in panel A was significant or close to significance, three additional repeats of the points of interest were performed in order to verify the differences. Where significant differences were confirmed, the corresponding *P* value is indicated on the graphic.

Thus, while the expression of *DNMTs* was not altered by *in vitro* culture in G1+/G2+ and Global media, the embryonic expression of *TET1* and *TET2* was significantly reduced at later stages.

Effect of *in vitro* culture on the expression of retrovirus sequences {#dew214s12f}
----------------------------------------------------------------------

We then wanted to assess whether the different culture conditions could have an impact on gene expression. In order to test this hypothesis, we chose to analyze the expression of two endogenous retroviral sequences (ERVs), belonging to two different families of retroviruses, thereafter referenced as *ERVA* and *ERVB*. Indeed, ERVs are known to be regulated by DNA methylation ([@dew214C47]) and their expression could thus be affected by modifications of this mark after *in vitro* culture. Moreover, we had previously identified those ERVs as transiently expressed at the time of EGA during development (belonging to the 'LHL' cluster as published in ([@dew214C27])). We first analyzed the expression of *ERVA* and *ERVB* in three independent experiments (Fig. [5](#dew214F5){ref-type="fig"}A), and performed three additional experiments for stages where we could detect a significant or close to significant difference between the various conditions (Fig. [5](#dew214F5){ref-type="fig"}B). We confirm that both *ERVA* and *ERVB* are strongly expressed at the time of EGA (Fig. [5](#dew214F5){ref-type="fig"}A). *ERVA* expression had already reached its peak at the 8-cell stage, and subsequently decreased until the blastocyst stage (96 hpc), where it was barely detectable. *ERVB* expression peaked later, between the 8-cell and morula stages, and decreased at the blastocyst stage. At first glance, the global dynamics of *ERVA* retrovirus did not seem to be affected by *in vitro* culture: its expression increased strongly between the 4- and 8-cell stages and decreased gradually between the 8-cell and blastocyst stages (Fig. [5](#dew214F5){ref-type="fig"}A). However, *in vitro* culture affected the levels of *ERVA* expression at certain stages. At the 8-cell stage, *ERVA* expression in embryos cultured in G1+/G2+ was statistically higher than in embryos cultured in Global, although there was no statistical difference between either *in vitro* condition and the *in vivo* one (Fig. [5](#dew214F5){ref-type="fig"}B). Moreover, *ERVA* expression levels at the blastocyst stage (96 hpc) remained higher in *in vitro* cultured embryos (*P* \< 0.01) (Fig. [5](#dew214F5){ref-type="fig"}B). As development is slightly slower in *in vitro* than *in vivo*, and because *ERVA* expression decreases between the morula and blastocyst stages, we wanted to check whether the observed difference was due to this developmental delay. Thus we compared *ERVA* expression in *in vitro* developed blastocysts at 96 hpc to its expression in *in vivo* developed blastocysts at earlier time points: i.e. 80 and 88 hpc. We confirmed that *ERVA* expression decreases during the blastocyst stage *in vivo*; however, this expression was still significantly higher in *in vitro* produced blastocysts at 96 hpc than in the earliest *in vivo* produced blastocysts (80 hpc) (*P* \< 0.01). Thus, the higher expression observed *in vitro* was not due to an induced developmental delay (Fig. [5](#dew214F5){ref-type="fig"}B). The expression pattern of *ERVB* also seemed to be affected by *in vitro* culture (Fig. [5](#dew214F5){ref-type="fig"}A). At the 8-cell stage, *ERVB* expression was higher in *in vitro* produced embryos than in *in vivo* produced ones (Fig. [5](#dew214F5){ref-type="fig"}B). In 96 hpc blastocysts, we also observed a higher *ERVB* expression after *in vitro* culture (*P* \< 0.01). But *ERVB* expression significantly decreased during the blastocyst stage *in vivo* and we could not detect a significant difference between 80 hpc*in vivo* produced blastocysts and 96 hpc *in vitro* produced ones so that we cannot rule out the possibility that the observed difference for *ERVB* at that stage was due to a developmental delay after *in vitro* culture (Fig. [5](#dew214F5){ref-type="fig"}B). Figure 5Expression of two endogenous retroviral sequences (ERVs) during rabbit preimplantation development in different conditions Panel **A:** expression kinetics of *ERVA* and *ERVB* in embryos developed *in vivo* (Vivo: black bars), cultured in G1+/G2+ (G1+/G2+: light grey bars) or in Global (Global: dark grey bars) medium. Each bar represents the mean of three independent experiments with standard deviations. 1: 1-cell embryos; 4: 4-cell embryos; 8: 8-cell embryos; 16: 16-cell embryos; M: morula; B: Blastocysts. Panel **B:** comparison of the expression levels of *ERVA* and *ERVB* in the three different conditions at the 8-cell, morula and blastocyst stages: when a difference between two conditions of development in the first set of experiments presented in panel A was significant or close to significance, three additional repeats of the points of interest were performed in order to verify the differences. For*in vivo* developed blastocysts (black dots), three different time points were analyzed: 80, 88 and 96 hpc and compared with *in vitro* cultured blastocysts (Global medium: dark grey dots; G1+/G2+ media: light grey dots) at 96 hpc; significant differences are displayed on the graphic. Each dot represents an independent measure.

In conclusion,*in vitro* culture affects the expression of both tested *ERVs*, albeit not at the same developmental stages.

Discussion {#dew214s13}
==========

Using two different media, the 'sequential' G1+/G2+ and the 'one-step' Global, we showed that *in vitro* culture impacts the evolution of DNA methylation and hydroxymethylation and that the effect observed is dependent on the medium used. In addition, *in vitro* culture alters the expression of *TET1* and *TET2,* two genes encoding proteins involved in DNA demethylation, but not the expression of *DNMTs*. Finally, we showed that the developmentally regulated expression of two endogenous retroviral sequences is altered after *in vitro* culture, suggesting that the effects we observed on global DNA methylation and hydroxymethylation may have an impact on gene expression.

DNA methylation and hydroxymethylation dynamics*in vivo* and the effect of *in vitro* culture {#dew214s13a}
---------------------------------------------------------------------------------------------

We had previously shown that the *in vivo* DNA methylation level decreases after the 4-cell stage in rabbit embryos and covers several cell cycles ([@dew214C46]). In the present study, we refined this analysis by separating embryos at the 4- and 8-cell stage depending on their DNA content and thus on their position in the cell cycle. This allowed us to show that DNA methylation decrease starts during the 4-stage. In addition, the drop we observe between the end of 4-cell late and 8-cell early stages shows that an active demethylation mechanism is at play.

By contrast, DNA hydroxymethylation also decreases during the 4- and 8-cell stages but does not change between the 4- and 8-cell stages, suggesting passive loss of this mark as in mouse embryo ([@dew214C19]). However, as active demethylation, and the consequent formation of new 5hmeC, takes place simultaneously, DNA hydroxymethylation loss cannot only be passive and 5hmeC conversion to 5-formylcytosine (5fC) and 5-carboxylcytosine (5-caC) probably also takes place.

We also showed that DNA methylation and hydroxymethylation kinetics in embryos cultured *in vitro* are altered. It is also interesting to note that the levels of both marks appear much more variable after *in vitro* culture (Figs [2](#dew214F2){ref-type="fig"} and [3](#dew214F3){ref-type="fig"}); this variability probably reveals both interindividual and interblastomere heterogeneity in the response to suboptimal environmental conditions. As the rabbits used in this study are not isogenic, genetic differences between same stage embryos could be responsible for inter-individual differences, while the absence of gap junctions during cleavage stages and the resulting metabolic heterogeneity between early blastomeres ([@dew214C2]) could contribute to inter-blastomere variability.

Indeed, DNA methylation increases between the 4-cell late and 8-cell early stages after culture in G1+/G2+, while no decrease is observed until the 8-cell stage after culture in Global medium. This suggests an increase of DNA methylation activity in G1+/G2+, and an increase of DNA methylation and/or a decrease of DNA demethylation activity in Global media. Yet, at these stages, we did not observe any change in the expression of *DNMTs* or *TETs*. Thus, the differences we observe should be explained either by changes in proteins levels or by modifications of their activity. This remains to be determined.

In embryos cultured in G1+/G2+ media, DNA hydroxymethylation follows the DNA methylation increase between the 4- and 8-cell stages, which is consistent since DNA hydroxymethylation can only be generated through the oxidation of methylated DNA ([@dew214C51]; [@dew214C11]). However, as mentioned above, the stability of DNA methylation levels in embryos cultured in Global medium has no apparent effect on the kinetics of DNA hydroxymethylation. This suggests that the activity of TET enzymes in both media may be different at this stage. Assessing TET enzymes activities is all the more crucial as we observed an increase of DNA hydroxymethylation between the 16/32-cell and morula stages after *in vitro* culture in both conditions, surprisingly correlated with a decrease in *TET1* and *TET2* expression. Alternatively, as TET enzymes cannot only catalyze the conversion of 5meC to 5hmeC but also the conversion of 5hmeC to 5fC and 5caC, we may hypothesize that the latter reactions require higher concentrations of TET enzymes.

The effect of *in vitro* culture and its implications regarding the tested media {#dew214s13b}
--------------------------------------------------------------------------------

Thus, both *in vitro* culture conditions have different impacts on DNA methylation and hydroxymethylation dynamics. In rabbit embryos cultured in G1+/G2+ media but not in Global medium, both DNA methylation and hydroxymethylation seem perturbed around the time of EGA, which also corresponds to the time of medium change between G1+ and G2+ (8-cell stage). This timing corresponds to the one recommended by Vitrolife for the medium change in human embryos. Our results however suggest that the G1+ medium may not be entirely adapted to development when the embryo is 'preparing' for EGA. This cannot be explained by the lack of carbohydrates, as the concentrations of glucose, lactate, pyruvate and citrate are very similar in both G1+ and Global, but may be related to the absence of essential amino acids in G1+ medium ([@dew214C36]), while those are present in rabbit oviductal fluid ([@dew214C28]). Conversely, the Global medium appears adapted to the EGA developmental period but may not be suited to the later developmental stages (from 16/32-cell).

We show here that the expression of both endogenous retroviral sequences we tested is affected by *in vitro* culture at critical points of development: around EGA and at the blastocyst stage. Interestingly, expression of these *ERV* genes is under the control of promoters located in their Long Terminal Repeats (LTR); while the *ERV* sequences we quantified are found as about 40 and 60 copies in the rabbit genome respectively, their LTRs are scattered throughout the genome and may regulate many endogenous genes ([@dew214C42]). The effects we observe for these two sequences may thus reflect a deregulation of many other genes. Moreover, differences in DNA methylation may affect the expression of other genes independently of these LTRs.

In conclusion, additional studies will need to be conducted to identify gene expression perturbations on a broader scale and to determine their relationship with epigenetic perturbations due to the culture conditions. One of our aims in this study was to provide new insight to help the choice of culture media for human ART: sequential or 'one-step' media. Unexpectedly, neither*in vitro* culture condition appeared closer to *in vivo* development. Further analyses at later stages of rabbit embryo development should however provide useful data to help with this difficult choice. Especially, remethylation occurs differently in the embryonic and extraembryonic lineages of peri-implantation blastocysts (Salvaing *et al*., submitted) and could thus differentially maintain, amplify or erase the early epigenetic differences we observe here. It will be important to perform those analyses separately in embryonic and extraembryonic tissues just after this remethylation step but also in the perinatal and postnatal periods to decipher whether the early alterations we observe have long term effects.

Supplementary data {#dew214s14}
==================

[Supplementary data are available at http://humrep.oxfordjournals.org/](http://HUMREP.oxfordjournals.org/lookup/suppl/doi:10.1093/humrep/dew214/-/DC1).

###### Supplementary Data

The authors would like to thank Luc Jouneau for his help with statistical analyses. The authors are indebted to members of Unité Commune d\'Expérimentation Animale (UCEA) responsible for our rabbit facility. They are grateful to Eugénie Canon, Vincent Brochard, Catherine Archilla and Linda Maulny for excellent technical assistance, to Anne Jeandin for participating in the early phases of this work, and to Geneviève Jolivet for providing primer sequences for rabbit DNMT. They also thank Pierre Adenot and the MIMA2 facility for access to the Apotome microscopy and the Région Ile-de-France for funding this system.

Authors' roles {#dew214s15}
==============

J.S., V.D., N.P., N.D. and N.B. designed the experiments. J.S., N.P., M.N.B., S.V., E.P., C.B. and N.D. performed the experiments. J.S., M.N.B., N.P., S.V. and V.D. analyzed the results. J.S., N.P. and V.D. wrote the article. All authors have critically revised the article.

Funding {#dew214s16}
=======

This work was supported by an 'AMP diagnostic prénatal et diagnostic génétique' 2012 grant from the French Agence de la Biomédecine.This study was performed within the framework of ANR LABEX 'REVIVE' (ANR-10-LABX-73). Authors are members of RGB-Net (TD 1101) and Epiconcept (FA 1201) COST actions.

Conflict of interest {#dew214s17}
====================

The authors declare that they have no conflict of interests.

[^1]: F, forward primer; R, reverse primer.
